BlackRock’s TriSalus Life Sciences TLSI Stock Holding History

BlackRock’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6M	Sell	1,499,547 -34,789	-2%	-$170K	﹤0.01%	3754
2025 Q4	$10.7M	Buy	1,534,336 +746,472	+95%	+$4.18M	﹤0.01%	3427
2025 Q3	$3.66M	Buy	787,864 +166,175	+27%	+$778K	﹤0.01%	3906
2025 Q2	$3.39M	Buy	621,689 +591,419	+1,954%	+$3.17M	﹤0.01%	3918
2025 Q1	$167K	Hold	30,270	–	–	﹤0.01%	4639
2024 Q4	$152K	Hold	30,270	–	–	﹤0.01%	4679
2024 Q3	$140K	Hold	30,270	–	–	﹤0.01%	4608
2024 Q2	$167K	Sell	30,270 -11,900	-28%	-$101K	﹤0.01%	4585
2024 Q1	$411K	Buy	42,170 +40,900	+3,220%	+$378K	﹤0.01%	4423
2023 Q4	$10.7K	Buy	+1,270	New	+$6.54K	﹤0.01%	5137
2022 Q4	–	Sell	-2,728,633	Closed	-$27.1M	–	5841
2022 Q3	$27.1M	Sell	2,728,633 -318	-0%	-$3.15K	﹤0.01%	2862
2022 Q2	$26.9M	Hold	2,728,951	–	–	﹤0.01%	2919
2022 Q1	$26.7M	Hold	2,728,951	–	–	﹤0.01%	2988
2021 Q4	$27M	Sell	2,728,951 -21,049	-0.8%	-$209K	﹤0.01%	3093
2021 Q3	$27.3M	Hold	2,750,000	–	–	﹤0.01%	3078
2021 Q2	$26.7M	Hold	2,750,000	–	–	﹤0.01%	3122
2021 Q1	$26.6M	Buy	+2,750,000	New	+$27.9M	﹤0.01%	3028

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

BlackRock's TLSI Position: Q1 2026 in Review

BlackRock reduced its TriSalus Life Sciences (TLSI) stake by 2.3% in Q1 2026, selling an estimated $170K and leaving 1,499,547 shares worth $6M. The position accounts for ﹤0.01% of the portfolio, ranked #3754.

BlackRock first reported a position in TLSI in Q1 2021 and has held it in 17 quarters since. The position peaked at $27.3M in Q3 2021. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

BlackRock held 1,499,547 shares of TriSalus Life Sciences worth $6M as of Q1 2026.
BlackRock sold 34,789 TriSalus Life Sciences shares in Q1 2026, an estimated $170K.
TriSalus Life Sciences made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3754 holding.
BlackRock first reported a position in TriSalus Life Sciences in Q1 2021 and has held it in 17 quarters since.
BlackRock's TriSalus Life Sciences position peaked at $27.3M in Q3 2021.
84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.